May 21 (Reuters) - GSK plc:
* GSK PLC - POSITIVE PHASE III ASTHMA RESULTS FOR DEPEMOKIMAB
* GSK: PRIMARY ENDPOINTS MET IN SWIFT-1 AND SWIFT-2 TRIALS Source text for Eikon: Further company coverage:
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,614 GBX | -8.62% | -6.58% | +12.09% |
03:28pm | Trending : GSK Shares Tumble on Zantac's Legal Setback | DJ |
03:19pm | Sector Update: Health Care Stocks Steady Premarket Monday | MT |
May 21 (Reuters) - GSK plc:
* GSK PLC - POSITIVE PHASE III ASTHMA RESULTS FOR DEPEMOKIMAB
* GSK: PRIMARY ENDPOINTS MET IN SWIFT-1 AND SWIFT-2 TRIALS Source text for Eikon: Further company coverage:
1st Jan change | Capi. | |
---|---|---|
+12.09% | 9.17TCr | |
+41.50% | 74TCr | |
+32.40% | 60TCr | |
-5.31% | 35TCr | |
+17.21% | 32TCr | |
+4.67% | 28TCr | |
+16.60% | 24TCr | |
+9.65% | 21TCr | |
-5.15% | 21TCr | |
+7.67% | 16TCr |